Companies: 10,795·Total market cap: $144.5T
Co-Diagnostics, Inc.

Co-Diagnostics, Inc.

CODXNASDAQHealthcare● Active
$5.12
$-0.51(-9.06%)
Market Cap$5715180
P/E Ratio
52W High$46.5
52W Low$1.26
Overview

Co-Diagnostics, Inc.(CODX)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · CODX · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.62M$3.92M$6.81M$34.22M$97.89M
Cost of Revenue$0.22M$1.00M$4.18M$5.48M$11.57M
Gross Profit$0.40M$2.92M$2.63M$28.74M$86.31M
Gross Margin %(computed)64.28%74.48%38.57%83.98%88.18%
Operating Expenses
R&D Expenses$19.14M$20.98M$22.96M$17.44M$14.96M
G&A Expenses$9.06M$16.16M$14.28M$14.26M$11.55M
Total Operating Expenses$31.68M$43.00M$45.33M$55.72M$40.25M
Operating Income($31.28M)($40.08M)($42.71M)($26.98M)$46.06M
Operating Margin %(computed)-626.92%-78.85%47.06%
Interest Income$0.29M$1.09M$1.16M$0.70M$0.05M
Interest Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Income Before Tax($48.51M)($37.58M)($38.11M)($18.85M)$45.64M
Income Tax Expense($1.62M)$0.06M($2.78M)($4.61M)$8.98M
Net Income($46.90M)($37.64M)($35.33M)($14.24M)$36.66M
Net Margin %(computed)-961.37%-518.68%-41.61%37.45%
Per Share & EBITDA
EPS (Basic)$-35.25$-37.20$-36.00$-13.57$38.10
Wtd Avg Shares1.33M1.01M0.98M1.05M0.96M
EBITDA($30.18M)($38.70M)($41.48M)($10.31M)$46.40M
EBITDA Margin %(computed)-988.57%-608.86%-30.13%47.40%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · M

深入了解Co-Diagnostics, Inc.

关于Co-Diagnostics, Inc.(CODX)损益表

Co-Diagnostics, Inc.(CODX)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,CODX实现营收$0.00B,毛利润$0.00B(毛利率64.28%),净利润($0.05B)(净利率-7533.62%)。

常见问题

CODX · 4 问

Co-Diagnostics, Inc.(CODX)2025财年营收为$0.00B,同比down84.1%。

CODX revenueCODX salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08